Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cossum

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Research|November 21, 2000
Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivityI Lebedeva, R Rando, J Ojwang, et al.
Anticancer Research|June 16, 1999
Comparison of annamycin to adriamycin in cardiac and MDR tumor cell systemsD Kolonias, T Podona, N Savaraj, et al.
The Journal of Urology|July 18, 2001
Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotidesI Lebedeva, A Raffo, R Rando, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Differential antifungal activity of isomeric forms of nystatinL Ostrosky-Zeichner, S Bazemore, V L Paetznick, et al.
Endocrinology|February 1, 1993
Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh-inhibin A and [125I]rh-activin A in immature female and male ratsT K Woodruff, L Krummen, S A Chen, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
Phase I study of liposomal annamycinD J Booser, R Perez-Soler, P Cossum, et al.
Endocrinology|January 1, 1993
Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluidsL A Krummen, T K Woodruff, G DeGuzman, et al.
Nature|April 12, 1990
Biological properties of a CD4 immunoadhesinR A Byrn, J Mordenti, C Lucas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Research|November 21, 2000
Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivityI Lebedeva, R Rando, J Ojwang, et al.
Anticancer Research|June 16, 1999
Comparison of annamycin to adriamycin in cardiac and MDR tumor cell systemsD Kolonias, T Podona, N Savaraj, et al.
The Journal of Urology|July 18, 2001
Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotidesI Lebedeva, A Raffo, R Rando, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Differential antifungal activity of isomeric forms of nystatinL Ostrosky-Zeichner, S Bazemore, V L Paetznick, et al.
Endocrinology|February 1, 1993
Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh-inhibin A and [125I]rh-activin A in immature female and male ratsT K Woodruff, L Krummen, S A Chen, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
Phase I study of liposomal annamycinD J Booser, R Perez-Soler, P Cossum, et al.
Endocrinology|January 1, 1993
Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluidsL A Krummen, T K Woodruff, G DeGuzman, et al.
Nature|April 12, 1990
Biological properties of a CD4 immunoadhesinR A Byrn, J Mordenti, C Lucas, et al.
Pageof 1